Keyphrases
Hemodialysis
96%
Hemodialysis Patients
74%
Dialysis
72%
Residual Renal Function
34%
Chronic Kidney Disease
31%
Maintenance Hemodialysis Patients
21%
Patient Experience
20%
End-stage Renal Disease
18%
Hemodiafiltration
18%
South Asian
18%
Renal Replacement Therapy
18%
UK Renal Registry
18%
Dialysis Patients
18%
Quality of Life
17%
Beck Depression inventory-II (BDI-II)
17%
Depressive Symptoms
15%
High-flux Hemodialysis
15%
Kidney Care
14%
End-stage Kidney Disease
14%
Total Energy Expenditure
14%
Diabetes
14%
Peritoneal Dialysis
13%
Resting Energy Expenditure
13%
Comorbidity
12%
Incremental Hemodialysis
12%
Elderly Patients
12%
β2-microglobulin (β2-MG)
11%
Asian Patients
11%
Advanced Kidney Disease
10%
Peritoneal Dialysis Patients
9%
Dialysis Dose
9%
Randomized Controlled Trial
9%
Non-adherence
9%
Patient-reported Experience Measures
9%
Specific Analysis
9%
Older Patients
9%
High Dose
9%
Urea Clearance
9%
Patient-reported Experience
8%
Intravenous Iron
8%
Illness Perceptions
8%
United Kingdom
8%
Inflammation
8%
Ethnic Minorities
8%
Post-dialysis
8%
End-of-life Care
8%
Type 2 Diabetes Mellitus (T2DM)
8%
Endotoxin
7%
Kidney Patients
7%
End-stage Renal Disease Patients
7%
Medicine and Dentistry
Hemodialysis
100%
Chronic Kidney Disease
38%
End Stage Renal Disease
36%
Kidney Function
32%
Nephropathy
21%
Quality of Life
21%
Patient Experience
17%
Peritoneal Dialysis
17%
Renal Replacement Therapy
16%
Randomized Controlled Trial
16%
Prevalence
14%
Diabetes
14%
Transplantation
12%
Elderly Patient
12%
Renal Failure
10%
Disease
10%
Comorbidity
10%
Diabetes Mellitus
10%
Acute Kidney Injury
9%
Hemodiafiltration
9%
Energy Expenditure
8%
Endotoxin
7%
Beck Depression Inventory
7%
Home Hemodialysis
7%
Resting Energy Expenditure
7%
End of Life Care
7%
Maturity Onset Diabetes of the Young
7%
Kidney Transplantation
6%
Arteriovenous Fistula
6%
Blood Vessel Calcification
6%
Creatinine
6%
Infection
6%
Patient Referral
6%
Patient-Reported Outcome
5%
Endotoxemia
5%
Diabetic Nephropathy
5%
Central Venous Catheter
5%
Depression
5%
COVID-19
5%